Gene co-expression network analysis of dysferlinopathy: Altered cellular processes and functional prediction of TOR1AIP1, a novel muscular dystrophy gene
- PMID: 28110863
- DOI: 10.1016/j.nmd.2016.10.011
Gene co-expression network analysis of dysferlinopathy: Altered cellular processes and functional prediction of TOR1AIP1, a novel muscular dystrophy gene
Abstract
Dysferlinopathy, caused by a dysferlin gene mutation, is a clinically heterogeneous autosomal recessive muscle disease characterized by progressive muscle degeneration. The dysferlin protein's functions and dysferlinopathy disease pathogenesis are not fully explored, and there is no specific treatment available that can alter the disease progression. This study uses publicly available dysferlinopathy patient microarray data to construct a gene co-expression network and investigates significant cellular pathways and their key players in dysferlinopathy pathogenesis. Extracellular matrix deposition, inflammation, mitochondrial abnormalities and protein degradation were found to be important in dysferlinopathy. Out of the hub genes, OXR1 and TIMP1 were selected through literature search as candidate genes for possible biomarker and molecular therapeutic target studies. A recently identified muscular dystrophy gene TOR1AIP1 was detected as a hub gene in dysferlinopathy. Co-expression and protein sequence feature analysis were adopted to predict TOR1AIP1's function. Our results suggest that LAP1 protein encoded by TOR1AIP1 may play a role in protein degradation possibly through transcriptional regulation in muscle tissue. These findings extend dysferlinopathy pathogenesis by presenting key genes and also suggest a novel function for a poorly characterized gene.
Keywords: Co-expression; Dysferlin; Muscle dystrophy; TOR1AIP1.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.Mol Ther. 2017 Sep 6;25(9):2150-2162. doi: 10.1016/j.ymthe.2017.05.013. Epub 2017 Jun 16. Mol Ther. 2017. PMID: 28629822 Free PMC article.
-
[Progressive muscular weakness of lower limbs revealing a limb girdle muscular dystrophy].Rev Med Liege. 2017 Jul;72(7-8):373-376. Rev Med Liege. 2017. PMID: 28795552 French.
-
The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants.BMC Neurol. 2022 Nov 1;22(1):398. doi: 10.1186/s12883-022-02905-w. BMC Neurol. 2022. PMID: 36319958 Free PMC article.
-
Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.BMC Med Genomics. 2022 Jun 20;15(1):139. doi: 10.1186/s12920-022-01284-y. BMC Med Genomics. 2022. PMID: 35725460 Free PMC article. Review.
-
Genetic mutations strengthen functional association of LAP1 with DYT1 dystonia and muscular dystrophy.Mutat Res Rev Mutat Res. 2015 Oct-Dec;766:42-7. doi: 10.1016/j.mrrev.2015.07.004. Epub 2015 Aug 5. Mutat Res Rev Mutat Res. 2015. PMID: 26596547 Review.
Cited by
-
Key Genes Regulating Skeletal Muscle Development and Growth in Farm Animals.Animals (Basel). 2021 Mar 16;11(3):835. doi: 10.3390/ani11030835. Animals (Basel). 2021. PMID: 33809500 Free PMC article. Review.
-
TOR1AIP1-Associated Nuclear Envelopathies.Int J Mol Sci. 2023 Apr 7;24(8):6911. doi: 10.3390/ijms24086911. Int J Mol Sci. 2023. PMID: 37108075 Free PMC article. Review.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous